Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gyuris

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Molecular Endocrinology (Baltimore, Md.)|February 1, 1995
Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptorJ W Lee, H S Choi, J Gyuris, et al.
Current Protocols in Cell Biology|January 30, 2008
Interaction trap/two-hybrid system to identify interacting proteinsE A Golemis, I Serebriiskii, R L Finley, et al.
Nature|April 29, 1993
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53J D Oliner, J A Pietenpol, S Thiagalingam, et al.
Current Protocols in Protein Science|April 23, 2008
Interaction trap/two-hybrid system to identify interacting proteinsE A Golemis, I Serebriiskii, R L Finley, et al.
Current Protocols in Molecular Biology|February 12, 2008
Interaction trap/two-hybrid system to identify interacting proteinsE A Golemis, I Serebriiskii, R L Finley, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 30, 2000
Novel chimeric p16 and p27 molecules with increased antiproliferative activity for vascular disease gene therapyL Lamphere, L Tsui, S Wick, et al.
The EMBO Journal|May 1, 1989
Positive and negative control of nod gene expression in Rhizobium meliloti is required for optimal nodulationE Kondorosi, J Gyuris, J Schmidt, et al.
Oncogene|April 24, 1997
Interaction between Cdc37 and Cdk4 in human cellsL Lamphere, F Fiore, X Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2001
p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasiaJ G McArthur, H Qian, D Citron, et al.
Cancer Research|July 15, 1995
APC binds to the novel protein EB1L K Su, M Burrell, D E Hill, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Molecular Endocrinology (Baltimore, Md.)|February 1, 1995
Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptorJ W Lee, H S Choi, J Gyuris, et al.
Current Protocols in Cell Biology|January 30, 2008
Interaction trap/two-hybrid system to identify interacting proteinsE A Golemis, I Serebriiskii, R L Finley, et al.
Nature|April 29, 1993
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53J D Oliner, J A Pietenpol, S Thiagalingam, et al.
Current Protocols in Protein Science|April 23, 2008
Interaction trap/two-hybrid system to identify interacting proteinsE A Golemis, I Serebriiskii, R L Finley, et al.
Current Protocols in Molecular Biology|February 12, 2008
Interaction trap/two-hybrid system to identify interacting proteinsE A Golemis, I Serebriiskii, R L Finley, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 30, 2000
Novel chimeric p16 and p27 molecules with increased antiproliferative activity for vascular disease gene therapyL Lamphere, L Tsui, S Wick, et al.
The EMBO Journal|May 1, 1989
Positive and negative control of nod gene expression in Rhizobium meliloti is required for optimal nodulationE Kondorosi, J Gyuris, J Schmidt, et al.
Oncogene|April 24, 1997
Interaction between Cdc37 and Cdk4 in human cellsL Lamphere, F Fiore, X Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2001
p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasiaJ G McArthur, H Qian, D Citron, et al.
Cancer Research|July 15, 1995
APC binds to the novel protein EB1L K Su, M Burrell, D E Hill, et al.
Pageof 4